Yeah. I think there has to be some covering if anyone has been paying attention. B-OM is having an interim review of 38 patients right now(if I understood correctly) which could create a phase 2/3 immediately. The same option for B-ABSSI has that same option with a preliminary reviewed planned. So exciting times ahead. Feel bad for those working hard on trying to bash the company and it's progress. They are either part of the accumulation (which I am betting is bigger than the baby bashers anyway) or they are going to miss the boat!

GLTM